The Permeability Barrier in Essential Fatty Acid Deficiency: Evidence for a Direct Role for Linoleic Acid in Barrier Function

      This paper is only available as a PDF. To read, Please Download here.
      Essential fatty acid (EFA) deficient rodents demonstrate abnormal epidermal permeability barrier function and differentiation, defects which can be corrected by either topical or systemic administration of linoleic acid. Since linoleic acid is a precursor of prostaglandins, correction of the defect in barrier function may either reflect a prostaglandin-mediated return toward normal epidermal differentiation, or, instead, a direct effect of linoleic acid. To test these possibilities severely EFA-deficient mice were pretreated daily with indomethacin and/or 5,8,11,14-eicosatetrayeonic acid, and then placed on normal (linoleic acid-supplemented) diets. Endogenous formation of prostaglandin E 2 was determined by thin-layer chromatography after transformation into prostaglandin B 2 with ethanolic-hydrochloric acid. Animals treated with both indomethacin and TYA demonstrated substantial reductions in prostaglandin E 2 levels in liver and skin. Animals replenished with linoleic acid invariably demonstrated a rapid return of barrier function toward normal whether or not they were blockaded, while non-replenished animals, with or without inhibition of prostaglandin biosynthesis, demonstrated continued deterioration in barrier function. In other experiments, topically applied linoleic acid rapidly reversed the defect in barrier function at the sites of application prior to systemic correction of the EFA deficient state. These results suggest that: (1) defective cutaneous barrier function in EFA deficiency can be corrected locally without prior systemic reversal of the deficiency state; and (2) that linoleic acid may play a direct role in the epidermal permeability barrier independent of its role in prostaglandin metabolism.

      References

        • Alfin-Slater R.B.
        Essential fatty acids—Recent developments, Lipid.
        Pharmacology. 1976; 2: 43-82
        • Holman R.T.
        Essential fatty acids in human nutrition, International Symposium on Function and Biosynthesis of Lipids.
        Adv Exp Med Biol. 1977; 83: 515-534
        • Basnajake V.
        • Sinclair H.M.
        Popjak G. LeBreton E. The effects of deficiency of essential fatty acids upon the skin, Biochemical Problems of Lipids. Butterworth, London1956: 476-484
        • Elias P.M.
        • Brown B.E.
        The mammalian cutaneous permeability barrier: Defective barrier function in essential fatty acid deficiency correlates with abnormal intercellular lipid deposition.
        Lab Invest. 1978; 39: 574-583
        • Lowe N.J.
        • Stoughton R.B.
        Essential fatty acid deficient hairless mouse: A model of chronic epidermal hyperproliferation.
        Br J Dermatol. 1977; 96: 155-162
        • Menton D.N.
        The effects of essential fatty acid deficiency on the skin of the mouse.
        Am J Anat. 1968; 122: 337-356
        • Prottey C.
        Essential fatty acids and the skin.
        Br J Dermatol. 1976; 94: 579-587
        • Friedman Z.
        • Shochat S.J.
        • Maisels J.
        • Marks K.H.
        • Lamberth E.L.
        Correction of essential fatty acid deficiency in newborn infants by cutaneous application of sunflower-seed oil.
        Pediatrics. 1976; 58: 630-634
        • Press M.
        • Hartop P.J.
        • Prottey C.
        Correction of essential fatty acid-deficiency in man by the cutaneous application of sunflower-seed ou.
        Lancet. 1974; 1: 597-599
        • Prottey C.
        • Hartop P.J.
        • Press M.
        Correction of the cutaneous manifestations of essential fatty acid deficiency in man by the application of sunflower-seed oil to the skin.
        J Invest Dermatol. 1975; 64: 228-234
        • Ziboh V.A.
        • Hsia S.L.
        Effects of prostaglandin E2 on rat skin: Inhibition of sterol ester biosynthesis and clearing of scaly lesions in essential fatty acid deficiency.
        J Lipid Res. 1972; 13: 458-467
        • Williams M.A.
        • Tamai K.T.
        • Hincenbergs I.
        • McIntosh D.J.
        Hydrogenated coconut oil and tissue fatty acids in EFA-depleted and EFA-supplemented rats.
        J Nutr. 1972; 102: 847-856
        • Thiels F.A.J.
        • Schutter K.
        Moisture meters for measuring the water balance of the human skin.
        Proc Toilet Goods Assoc. 1963; 40: 20
        • Bligh E.G.
        • Dyer W.J.
        A rapid method of total lipid extraction and purification.
        Canad J Biochem Physiol. 1959; 37: 911-917
        • Elias P.M.
        • Goerke J.
        • Friend D.S.
        Composition and influence on structure.
        J Invest Dermatol. 1977; 69: 535-546
        • Fulco A.J.
        • Mead J.F.
        Metabolism of essential fatty acids. VII. Origin of 5,8,11 eicosatrienoic acid in the fatty acid deficient rat.
        J Biol Chem. 1959; 234: 1411-1416
        • Ziboh V.A.
        Biosynthesis of prostaglandin E2 in human skin: Sub-cellular localization and inhibition by unsaturated fatty acids and antiinflammatory drugs.
        J Lipid Res. 1973; 14: 377-384
        • Bergstrom S.
        • Dressler F.
        • Krabisch L.
        • Ryhage R.
        • Sjovall J.
        The isolation and structure of a smooth muscle stimulating factor in normal sheep and pig lungs. Prostaglandin and related factors. 9.
        Ark Kemi. 1963; 20: 63-66
        • Bergstrom S.
        • Ryhage R.
        • Samuelsson B.
        • Sjovall S.
        Prostaglandin and related factors. 15. The structures of prostaglandin E1, F and F.
        J Biol Chem. 1963; 238: 3546-3555
        • Lowe N.J.
        • DeQuoy P.R.
        Linoleic acid effects on epidermal DNA synthesis and cutaneous prostaglandin levels in essential fatty acid deficiency.
        J Invest Dermatol. 1978; 70: 200-203
        • Flower R.J.
        Drugs which inhibit prostaglandin biosynthesis.
        Pharmacol Rev. 1974; 26: 33-67
        • Hammerstom S.
        • Lindgren J.A.
        • Marcelo C.
        • Duell E.A.
        • Andersen T.F.
        • Voorhees J.J.
        Arachidonic acid transformations in normal and psoriatic skin.
        J Invest Dermatol. 1979; 73: 180-193
        • Sadowski J.A.
        Metabolism and release of arachidonic acid by primary mouse epidermal cell cultures.
        Fed Proc. 1979; 38: 752a
        • VanDorp D.A.
        Essential fatty acids and prostaglandins, 24th International Congress of Pure and Applied Chemistry. 2. Butterworth, London1974: 117
        • Prottey C.
        • Hartop P.J.
        • Black J.G.
        • McCormack J.I.
        The repair of impaired epidermal barrier function in rats by the cutaneous application of linoleic acid.
        Br J Dermatol. 1976; 94: 13-21
        • Prottey C.
        Investigaion of functions of essential fatty acids in the skin.
        Br J Dermatol. 1977; 97: 29-38
        • Jelenko C.
        • Wheeler M.L.
        • Scott T.H.
        Studies in burns. X. Ethyl linoleate: The water-holding lipid of skin. A. The evidence.
        J Trauma. 1972; 12: 968-977
        • Jonsson C.E.
        • Anggard E.
        Biosynthesis and metabolism of prostaglandin E2 in human skin.
        Scand J Clin Lab Invest. 1972; 29: 289-296
        • Ziboh V.A.
        Biosynthesis of prostaglandin E2 in human skin: Sub-cellular localization and inhibition by unsaturated fatty acids and anti-inflammatory drugs.
        J Lipid Res. 1973; 14: 377-384
        • Hartop P.J.
        • Prottey C.
        Changes in transepidermal water loss and the composition of epidermal lecithin after application of pure fatty acid triglycerides to the skin of essential fatty acid-deficient rats.
        Br J Dermatol. 1976; 95: 255-264
        • Hammerstrom S.
        • Hamberg M.
        • Sammuelsson B.
        • Duell E.A.
        • Stawiski M.
        • Voorhees J.J.
        Increased concentrations of nonesterified arachidonic acid, 12, 1-hydroxy-5,8,10,14-eicosatrienoic acid, prostaglandin E2, and prostaglandin F2a. in epidermis of psoriasis.
        Proc Natl Acad Sci. 1975; 82: 5130-5134
        • Elias P.M.
        • Brown B.E.
        • Goerke J.
        • Fritsch P.
        • Gray G.M.
        • White R.J.
        Localization and composition of lipids in neonatal mouse stratum granulosum and stratum corneum.
        J Invest Dermatol. 1979; 73: 339-348
        • Gray G.M.
        • White R.J.
        Glycosphingolipids and ceramides in human and pig epidermis.
        J Invest Dermatol. 1978; 70: 336-341
        • Gray G.M.
        • White R.J.
        • Majer R.J.
        1-(3′-0′acyl)-β-glucosyl-N-dihydroxy-pentatriacontadienoylsphingosine, a major component of the glucosylceramides of pig and human epidermis.
        Biochim Acta. 1978; 528: 127-137